A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/46 (2006.01)
Patent
CA 2636991
Lysosomal storage diseases can be successfully treated using intraventricular delivery of the enzyme which is etiologically deficient in the disease. The administration can be performed slowly to achieve maximum effect. Surprisingly, effects are seen on both sides of the blood- brain barrier, making this an ideal delivery means for lysosomal storage diseases which affect both brain and visceral organs.
La présente invention concerne des maladies de stockage des lysosomes pouvant être traitées avec succès par une administration intraventriculaire de l~enzyme qui est étiologiquement insuffisante dans la maladie. L~administration peut être effectuée lentement pour obtenir un effet maximal. Il est surprenant de constater que des effets sont visibles sur les deux côtés de la barrière hématoencéphalique, faisant de ce procédé un moyen d~administration idéal pour des maladies de stockage des lysosomes affectant à la fois le cerveau et des organes viscéraux.
Cheng Seng H.
Dodge James
Passini Marco A.
Shihabuddin Lamya
Genzyme Corporation
Gowling Lafleur Henderson Llp
LandOfFree
Intraventricular enzyme delivery for lysosomal storage diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intraventricular enzyme delivery for lysosomal storage diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraventricular enzyme delivery for lysosomal storage diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1980062